Diabetes medical devices in the spotlight
Recent updates on $PODD, $TNDM, $MODD, et al.
Medtronic has called off its plans to buy EOFlow, a company making an insulin patch-pump that is embroiled in a patent dispute with Insulet ($PODD).
In May 2023, Medtronic announced the acquisition of EOFlow for $738M. EOFlow makes a patch pump similar to Insulet’s Omnipod. It is cleared in over 10 countries globally, but not yet approved in the US. EOFl…